177 related articles for article (PubMed ID: 17931693)
1. Analysis of a T-287C polymorphism in the tissue factor pathway inhibitor gene and identification of a repressor element in the promoter.
Amini Nekoo A; Iles D
Thromb Res; 2008; 121(6):813-9. PubMed ID: 17931693
[TBL] [Abstract][Full Text] [Related]
2. Functional characterization of polymorphisms in the human TFPI gene.
Skretting G; Stavik B; Landvik NE; Myklebust CF; Iversen N; Zienolddiny S; Sandset PM
Biochem Biophys Res Commun; 2010 Jun; 397(1):106-11. PubMed ID: 20519147
[TBL] [Abstract][Full Text] [Related]
3. Tissue factor pathway inhibitor polymorphisms in women with and without a history of venous thrombosis and the effects of postmenopausal hormone therapy.
Opstad TB; Eilertsen AL; Høibraaten E; Skretting G; Sandset PM
Blood Coagul Fibrinolysis; 2010 Sep; 21(6):516-21. PubMed ID: 20453636
[TBL] [Abstract][Full Text] [Related]
4. Association of Asn221Ser mutation in tissue factor pathway inhibitor-beta with plasma total tissue factor pathway inhibitor level.
Ishikawa J; Okada H; Kato H; Takeshita S; Honda S; Kawasaki T; Suehisa E; Tsuji H; Madoiwa S; Sakata Y; Kojima T; Murata M; Ikeda Y; Kokubo Y; Okamura T; Tomoike H; Miyata T
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):22-6. PubMed ID: 20523161
[TBL] [Abstract][Full Text] [Related]
5. Crucial roles of GATA-2 and SP1 in adrenomedullin-affected expression of tissue factor pathway inhibitor in human umbilical vein endothelial cells exposed to lipopolysaccharide.
Liu W; Zhu ZQ; Wang W; Zu SY; Zhu GJ
Thromb Haemost; 2007 May; 97(5):839-46. PubMed ID: 17479196
[TBL] [Abstract][Full Text] [Related]
6. Analysis of sequence variations in the promoter region of the human tissue factor pathway inhibitor 2 gene in apoplectic patients and blood donors.
Siegling S; Thyzel E; Glahn J; Kleesiek K; Götting C
Ann Hematol; 2006 Jan; 85(1):32-7. PubMed ID: 16247609
[TBL] [Abstract][Full Text] [Related]
7. A new T-287C polymorphism in the 5' regulatory region of the tissue factor pathway inhibitor gene. Association study of the T-287C and C-399T polymorphisms with coronary artery disease and plasma TFPI levels.
Moatti D; Haidar B; Fumeron F; Gauci L; Boudvillain O; Seknadji P; Olliver V; Aumont MC; de Prost D
Thromb Haemost; 2000 Aug; 84(2):244-9. PubMed ID: 10959696
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms of the tissue factor pathway inhibitor gene are associated with venous thromboembolism in the antiphospholipid syndrome and carriers of factor V Leiden.
Lincz LF; Adams MJ; Scorgie FE; Thom J; Baker RI; Seldon M
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):559-64. PubMed ID: 17762532
[TBL] [Abstract][Full Text] [Related]
9. The 536C-->T transition in the human tissue factor pathway inhibitor (TFPI) gene is statistically associated with a higher risk for venous thrombosis.
Kleesiek K; Schmidt M; Götting C; Schwenz B; Lange S; Müller-Berghaus G; Brinkmann T; Prohaska W
Thromb Haemost; 1999 Jul; 82(1):1-5. PubMed ID: 10456444
[TBL] [Abstract][Full Text] [Related]
10. Association of 4G/5G polymorphism in PAI1 promoter with PAI1 level in deep vein thrombosis.
Chen YL; Zhang JX; Wang PX; Cui RZ; Zhao FM; Mao YM; Li JY; Bi YY; Li H
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2005 Dec; 22(6):624-7. PubMed ID: 16331557
[TBL] [Abstract][Full Text] [Related]
11. The -33T-->C polymorphism in intron 7 of the TFPI gene influences the risk of venous thromboembolism, independently of the factor V Leiden and prothrombin mutations.
Ameziane N; Seguin C; Borgel D; Fumeron F; Moatti D; Alhenc-Gelas M; Grandchamp B; Aiach M; Emmerich J; de Prost D
Thromb Haemost; 2002 Aug; 88(2):195-9. PubMed ID: 12195688
[TBL] [Abstract][Full Text] [Related]
12. C-399T polymorphism in the promoter region of human tissue factor pathway inhibitor (TFPI) gene does not change the plasma TFPI antigen level and does not cause venous thrombosis.
Miyata T; Sakata T; Kumeda K; Uchida K; Tsushima M; Fujimura H; Kawasaki T; Kato H
Thromb Haemost; 1998 Aug; 80(2):345-6. PubMed ID: 9716167
[No Abstract] [Full Text] [Related]
13. Tissue factor pathway inhibitor relates to fibrin degradation in patients with acute deep venous thrombosis.
Sidelmann JJ; Bladbjerg EM; Gram J; Münster AM; Jespersen J
Blood Coagul Fibrinolysis; 2008 Jul; 19(5):405-9. PubMed ID: 18600090
[TBL] [Abstract][Full Text] [Related]
14. Regulatory region variability in the human presenilin-2 (PSEN2) gene: potential contribution to the gene activity and risk for AD.
Riazanskaia N; Lukiw WJ; Grigorenko A; Korovaitseva G; Dvoryanchikov G; Moliaka Y; Nicolaou M; Farrer L; Bazan NG; Rogaev E
Mol Psychiatry; 2002; 7(8):891-8. PubMed ID: 12232783
[TBL] [Abstract][Full Text] [Related]
15. Tissue factor pathway inhibitor anticoagulant activity: risk for venous thrombosis and effect of hormonal state.
Dahm A; Rosendaal FR; Andersen TO; Sandset PM
Br J Haematol; 2006 Feb; 132(3):333-8. PubMed ID: 16409298
[TBL] [Abstract][Full Text] [Related]
16. Transcription factor FOXP3: A repressor of the TFPI gene?
Skretting G; Andersen E; Myklebust CF; Sandset PM; Tinholt M; Iversen N; Stavik B
J Cell Biochem; 2019 Aug; 120(8):12924-12936. PubMed ID: 30861202
[TBL] [Abstract][Full Text] [Related]
17. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
Skretting G; Lien T; Sandset PM; Iversen N
Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
[TBL] [Abstract][Full Text] [Related]
18. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
[TBL] [Abstract][Full Text] [Related]
19. An IgE-associated polymorphism in STAT6 alters NF-kappaB binding, STAT6 promoter activity, and mRNA expression.
Schedel M; Frei R; Bieli C; Cameron L; Adamski J; Lauener R; Kabesch M
J Allergy Clin Immunol; 2009 Sep; 124(3):583-9, 589.e1-6. PubMed ID: 19665768
[TBL] [Abstract][Full Text] [Related]
20. No direct effect of the -521 C/T polymorphism in the human dopamine D4 receptor gene promoter on transcriptional activity.
Kereszturi E; Kiraly O; Barta C; Molnar N; Sasvari-Szekely M; Csapo Z
BMC Mol Biol; 2006 May; 7():18. PubMed ID: 16723017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
